Drawing for LEAP

USPTO serial 90046497

LEAP

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
YOUNG, THOMAS PAUL
Law office
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LEAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Crissa A. Cook

CRISSA A. COOK HOVEY WILLIAMS LLP10801 MASTIN BLVD., SUITE 1000OVERLAND PARK, KS 66210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Peptide-based chemical, biological, and diagnostic reagents and preparations for scientific, medical and veterinary research use; Peptide-based biological preparations, other than for medical use, namely, for use in biotechnological product development, manufacture of vaccines, drugs and medicines; Biochemical reagents in the form of peptide capsules, microspheres, micelles, or nanospheres used for non-medical purposes; Fertilizers in the form of peptide capsules, microspheres, micelles, or nanospheres used as vehicles to deliver active substances in the nature of horticultural preparations, plant nutrients, micronutrients, and soil amendmentsACTIVE—
005Preparations and substances for facilitating delivery of active substances, namely, a drug delivery agent in the form of peptide capsules, microspheres, micelles, or nanospheres for delivering nucleic acids, proteins, enzymes, small molecules, therapeutic drugs, organic compounds, plasmids, dyes, nutrients, minerals, colloidal metal, pesticides, insecticides, parasiticides, and fungicides to cells; Peptides for drug delivery, namely, drug delivery agents consisting of peptide capsules, microspheres, micelles, or nanospheres containing or attached to active substances that facilitate delivery of a wide variety of pharmaceutical or veterinary preparations; Carriers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of pharmaceutical or veterinary preparations; Diagnostic agents for medical or veterinary purposes, namely, diagnostic agents in the form of peptide capsules, microspheres, micelles, or nanospheres containing or attached to imaging agents for medical or veterinary purposes; Peptide-based preparations for destroying vermin; Peptide-based fungicides; Peptide-based herbicides; Imaging agents in the form of peptide capsules, microspheres, micelles, or nanospheres for medical and veterinary diagnostic purposes, namely, contrasting agents for ultrasound or near-infrared diagnostic imaging, diagnostic radiopharmaceutical agent for use in PET imaging, imaging agents for magnetic resonance imaging (MRI), radiopharmaceutical imaging agents for diagnosing and monitoring cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 10, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 10, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 26, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2020DOCKASSIGNED TO EXAMINER—
Aug 7, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 14, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance